NASAL DELIVERY OF GLUCOCORTICOIDS ENCAPSULATED IN CHITOSAN NANOPARTICLES FOR THE TREATMENT OF BRAIN PATHOLOGY IN THE ACID SPHINGOMYELINASE DEFICIENCY. | Publicación